FILE - This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Thursday, July 8, 2021, U.S. health regulators approved new prescribing instructions for the controversial Alzheimer's drug that are likely to limit use of the expensive therapy, which has faced an intense public backlash. WASHINGTON — U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug.
“Hearing these concerns, FDA determined that clarifications could be made to the prescribing information to address this confusion,” the agency said in an emailed statement. Despite the update, the FDA added that “some patients may benefit from ongoing treatment” if they develop more advanced Alzheimer’s.
Because of its price and broad approval some analysts have worried that Aduhelm could add tens of billions in new expenses to the U.S. health care system, particularly the federal government's Medicare program. Alzheimer’s affects about 6 million Americans, the vast majority old enough to qualify for Medicare.
Source: Healthcare Press (healthcarepress.net)
They mean backlash by scientists
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCNews - 🏆 10. / 86 Read more »
Source: WSJ - 🏆 98. / 63 Read more »
NPR Cookie Consent and ChoicesGood. Honestly. Why would they have banned it in the first place? I can't qwhite figure it out. FINA literally said they never had swimmers wear caps this size…lord forbid a woman have some big hair that they’re supposed to fit into a tiny swim cap. I have curly hair that is not even close to other women’s hair and I struggle with it! Get with the times 😑
Source: NPR - 🏆 96. / 63 Read more »
Source: papermagazine - 🏆 409. / 53 Read more »
Source: Newsweek - 🏆 468. / 52 Read more »
Source: ABC - 🏆 471. / 51 Read more »